Abstract: Compounds having somatostatin-like activity have been found to be useful as local anti-inflammatory agents in the treatment of such conditions as, for example, psoriasis, eczema, seborrhea, and other localized inflammatory and allergic conditions. Particularly useful are cyclic and bridged somatostatin analogs.
Type:
Grant
Filed:
September 2, 1987
Date of Patent:
May 31, 1988
Assignee:
Merck & Co., Inc.
Inventors:
Evan R. Morgan, Daniel F. Veber, Sanford L. Steelman